Q2 will likely see (imo)
1. Addition of US sales / Hispanic
2. Increasing SEA sales with expansion. Korea, Singapore starting.
3. Domestics sales increase post lockdown.
4. B2B increase. Deloraine.
5. Daigou channel opening and CBEC increase. China 3 child policy.
6. New product line (family nutrition).
So a number of tailwinds if things go smoothly. So Q2 should be a strong quarter
BUB chart, page-2618
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $107.1M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.5¢ | $45.76K | 382.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 79 | 4120787 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 634972 | 8 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| BUB (ASX) Chart |